CRISPR

CRISPR1-eif4e1c

ID

ZDB-CRISPR-240702-1

Name

CRISPR1-eif4e1c

Previous Names

None

Target

eif4e1c (1)

Sequence

5' - GGACATGTTTAAGCAGTGAG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
pd370	eif4e1c

Expression

Gene expression in Wild Types + CRISPR1-eif4e1c

No data available

Phenotype

Phenotype resulting from CRISPR1-eif4e1c

No data available

Phenotype of all Fish created by or utilizing CRISPR1-eif4e1c

Phenotype	Fish	Conditions	Figures
whole organism shortened, abnormal	eif4e1c^pd370/pd370	standard conditions	Fig. 4. from Dockery et al., 2026
whole organism decreased mass, abnormal	eif4e1c^pd370/pd370	standard conditions	Fig. 3. , Fig. 4. from Dockery et al., 2026
cardiac muscle cell decreased amount, abnormal	eif4e1c^pd370/pd370	standard conditions	Fig. 4. from Dockery et al., 2026
whole organism shortened, abnormal	eif4e1c^pd370/pd370; eif4ea^os81/os81	standard conditions	Fig. 3. from Dockery et al., 2026
whole organism decreased mass, exacerbated	eif4e1c^pd370/pd370; eif4ea^os81/os81	standard conditions	Fig. 3. from Dockery et al., 2026
heart Ab5-mef2 labeling decreased distribution, abnormal	eif4e1c^pd370/pd370; eif4ea^os81/os81	standard conditions	Fig. 3. from Dockery et al., 2026
cardiac muscle cell decreased amount, abnormal	eif4e1c^pd370/pd370; eif4ea^os81/os81	standard conditions	Fig. 3. from Dockery et al., 2026
whole organism viability, abnormal	eif4e1c^pd370/pd370; eif4ea^os81/os81	standard conditions	Fig. 3. from Dockery et al., 2026
heart Ab5-mef2 labeling decreased distribution, abnormal	eif4e1c^pd370/pd370; eif4eb^os83/os83	standard conditions	Fig. 4. from Dockery et al., 2026
whole organism decreased mass, exacerbated	eif4e1c^pd370/pd370; eif4eb^os83/os83	standard conditions	Fig. 4. from Dockery et al., 2026
whole organism shortened, exacerbated	eif4e1c^pd370/pd370; eif4eb^os83/os83	standard conditions	Fig. 4. from Dockery et al., 2026
cardiac muscle cell decreased amount, exacerbated	eif4e1c^pd370/pd370; eif4eb^os83/os83	standard conditions	Fig. 4. from Dockery et al., 2026
whole organism viability, abnormal	eif4e1c^pd370/pd370; eif4eb^os83/os83	standard conditions	Fig. 4. from Dockery et al., 2026
whole organism decreased mass, exacerbated	eif4e1c^pd370/pd370; eif4eb^os84/os84	standard conditions	Fig. 4. from Dockery et al., 2026
heart Ab5-mef2 labeling decreased distribution, abnormal	eif4e1c^pd370/pd370; eif4eb^os84/os84	standard conditions	Fig. 4. from Dockery et al., 2026
whole organism shortened, exacerbated	eif4e1c^pd370/pd370; eif4eb^os84/os84	standard conditions	Fig. 4. from Dockery et al., 2026
cardiac muscle cell decreased amount, exacerbated	eif4e1c^pd370/pd370; eif4eb^os84/os84	standard conditions	Fig. 4. from Dockery et al., 2026
whole organism viability, abnormal	eif4e1c^pd370/pd370; eif4eb^os84/os84	standard conditions	Fig. 4. from Dockery et al., 2026
whole organism viability, exacerbated	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os83/os83	standard conditions	Fig. 5. from Dockery et al., 2026
heart Ab5-mef2 labeling decreased distribution, abnormal	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os83/os83	standard conditions	Fig. 5. from Dockery et al., 2026
whole organism decreased mass, exacerbated	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os83/os83	standard conditions	Fig. 5. from Dockery et al., 2026
whole organism shortened, exacerbated	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os83/os83	standard conditions	Fig. 5. from Dockery et al., 2026
cardiac muscle cell decreased amount, exacerbated	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os83/os83	standard conditions	Fig. 5. from Dockery et al., 2026
whole organism viability, exacerbated	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os84/os84	standard conditions	Fig. 5. from Dockery et al., 2026
whole organism decreased mass, exacerbated	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os84/os84	standard conditions	Fig. 5. from Dockery et al., 2026
heart Ab5-mef2 labeling decreased distribution, abnormal	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os84/os84	standard conditions	Fig. 5. from Dockery et al., 2026
whole organism shortened, exacerbated	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os84/os84	standard conditions	Fig. 5. from Dockery et al., 2026
cardiac muscle cell decreased amount, exacerbated	eif4e1c^pd370/pd370; eif4ea^os81/+; eif4eb^os84/os84	standard conditions	Fig. 5. from Dockery et al., 2026

Citations